PMID: 7539034Jun 1, 1995Paper

Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants

The Journal of Experimental Medicine
P D SimitsekC Watts

Abstract

Bound antibodies can modulate antigen processing but it is not clear to what extent this affects antigen presentation. Here we show that presentation of T cell determinants in tetanus toxin can be either enhanced or suppressed as a direct consequence of antibody modulation of antigen processing in human B lymphoblastoid cells. Remarkably, a single bound antibody or its Fab fragment can simultaneously enhance the presentation of one T cell determinant by more than 10-fold while strongly suppressing the presentation of a different T cell determinant. Biochemical analysis demonstrates that both the suppressed and boosted determinants fall within an extended domain of antigen stabilized or "footprinted" by this antibody during proteolysis. These results demonstrate that bound antibodies can modulate the capture of peptides by class II major histocompatibility complex (MHC), thus manipulating the T cell response towards or away from particular determinants. Altered processing of protein-protein complexes leading to enhanced loading of class II MHC and substantially lowered threshold for T cell activation suggests a novel mechanism that might reveal "cryptic" self determinants.

References

Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R CibottiP Kourilsky
Mar 30, 1990·Science·H SchildH G Rammensee
Jul 1, 1989·The Journal of Cell Biology·H W Davidson, C Watts
Nov 9, 1989·Nature·G Gammon, E Sercarz
Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·C WattsH W Davidson
Apr 11, 1985·Nature·A Lanzavecchia
Oct 10, 1986·Nucleic Acids Research·N F Fairweather, V A Lyness
Jan 1, 1993·Annual Review of Immunology·E E SercarzK Moudgil
Oct 1, 1993·The Journal of Experimental Medicine·C Watts, A Lanzavecchia
Feb 1, 1993·The Journal of Experimental Medicine·M J Mamula

❮ Previous
Next ❯

Citations

Jan 1, 1996·Immunologic Research·G BenichouE V Fedoseyeva
Nov 15, 2002·International Journal of Hematology·Seon Ho LeeGian PaoloVisentin
Dec 7, 2007·Journal of Structural and Functional Genomics·Steven C AlmoStephen K Burley
Jun 5, 1998·Comparative Immunology, Microbiology and Infectious Diseases·E WattrangC Fossum
Dec 8, 2000·Journal of Neuroimmunology·A H CrossJ Lyons
Jan 19, 2000·Immunology Today·S M McLachlan, B Rapoport
May 1, 1997·Human Immunology·S C Schneider, E E Sercarz
Jun 1, 1996·Current Opinion in Immunology·A Lanzavecchia
Apr 2, 1998·Current Opinion in Immunology·S Amigorena, C Bonnerot
Nov 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C PetrarcaM Nuti
Apr 5, 2002·Microbes and Infection·Adrian Bot, Constantin Bona
Dec 9, 1998·Clinical and Experimental Immunology·E SarugeriE Bonifacio
Oct 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E Crowe
Apr 22, 2011·Antioxidants & Redox Signaling·Karen Taraszka Hastings, Peter Cresswell
Sep 29, 2007·Thyroid : Official Journal of the American Thyroid Association·George Carayanniotis
Aug 1, 1996·Immunological Reviews·V Barnaba
Oct 31, 1998·Immunological Reviews·J McCluskeyT P Gordon
Jan 13, 2000·Immunological Reviews·J van BergenF Koning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.